Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Humburg BA"'
Autor:
Humburg BA; Department of Psychology, University of Kentucky, Biomedical Biological Science Research Building, Room 447, 741 S. Limestone, Lexington, KY, 40536-0509, USA., Bardo MT; Department of Psychology, University of Kentucky, Biomedical Biological Science Research Building, Room 447, 741 S. Limestone, Lexington, KY, 40536-0509, USA. mbardo@uky.edu.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2023 Jul 01. Date of Electronic Publication: 2023 Jul 01.
Autor:
Hammerslag LR; Department of Psychology, University of Kentucky, Lexington, Kentucky, USA., Humburg BA; Department of Psychology, University of Kentucky, Lexington, Kentucky, USA., Malone SG; Department of Psychology, University of Kentucky, Lexington, Kentucky, USA., Beckmann JS; Department of Psychology, University of Kentucky, Lexington, Kentucky, USA., Saatman KE; Department of Physiology, and Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, USA., Grinevich V; Department of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Bardo MT; Department of Psychology, University of Kentucky, Lexington, Kentucky, USA.
Publikováno v:
Addiction biology [Addict Biol] 2022 Sep; Vol. 27 (5), pp. e13217.
Autor:
You ZB; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Gardner EL; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Galaj E; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Moore AR; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Buck T; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Jordan CJ; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Humburg BA; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Bi GH; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Xi ZX; Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA., Leggio L; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Medication Development Program, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA. lorenzo.leggio@nih.gov.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2022 Apr; Vol. 27 (4), pp. 2171-2181. Date of Electronic Publication: 2022 Jan 21.
Autor:
Humburg BA; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Jordan CJ; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Zhang HY; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Shen H; Synaptic Plasticity Section, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Han X; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Bi GH; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Hempel B; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Galaj E; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Baumann MH; Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA., Xi ZX; Addiction Biology Unit, Molecular Targets and Medications Discovery, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA.
Publikováno v:
Addiction biology [Addict Biol] 2021 Jul; Vol. 26 (4), pp. e13005. Date of Electronic Publication: 2021 Feb 03.
Autor:
Jordan CJ; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland chloe.jordan@nih.gov., Humburg BA; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Thorndike EB; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Shaik AB; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Xi ZX; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Baumann MH; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Newman AH; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland., Schindler CW; Molecular Targets and Medications Discovery Branch (C.J.J., B.A.H., A.B.S., Z.-X.X., A.H.N.), Designer Drug Research Unit (M.H.B., C.W.S.), and Preclinical Pharmacology Section (E.B.T., C.W.S.), Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland CSCHIND@intra.nida.nih.gov.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2019 Dec; Vol. 371 (3), pp. 602-614. Date of Electronic Publication: 2019 Sep 27.
Autor:
Hu G; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Niu F; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Humburg BA; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Liao K; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Bendi S; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Callen S; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Fox HS; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA., Buch S; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Publikováno v:
Oncotarget [Oncotarget] 2018 Jan 01; Vol. 9 (26), pp. 18648-18663. Date of Electronic Publication: 2018 Jan 01 (Print Publication: 2018).